Silver Book Fact

As of July 2014, 18 anticancer drugs received FDA approval after being designated breakthrough therapies.

AACR Cancer Progress Report 2014. Clin Cancer Res Web site. http://clincancerres.aacrjournals.org/content/20/19/4977.full. Published 2014

Reference

Title
AACR Cancer Progress Report 2014
Publication
Clin Cancer Res
Publication Date
Published 2014
Authors
American Association for Cancer Research
Volume & Issue
Volume 20, Issue S1
Pages
S1-S112
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349…  
  • The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.  
  • Every additional dollar spent on overall breast cancer treatment has produced health gains valued at $4.80.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.